Impact of FLT3-ITD location on cytarabine sensitivity in AML: a network-based approach

Leukemia. 2023 May;37(5):1151-1155. doi: 10.1038/s41375-023-01881-5. Epub 2023 Mar 25.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Cell Line, Tumor
  • Cytarabine* / pharmacology
  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy
  • Leukemia, Myeloid, Acute* / genetics
  • Mutation
  • fms-Like Tyrosine Kinase 3 / genetics

Substances

  • Cytarabine
  • fms-Like Tyrosine Kinase 3
  • FLT3 protein, human